INNOVATE Corp. (VATE) announced that the U.S. FDA has approved the MediBeacon TGFR for the assessment of kidney function in patients with ...
FDA bans Red Dye 3 from food supply after studies show potential cancer risk. Find out why this dye is no longer authorized ...
The reason for the recall is that "eggs from a positive Salmonella environment were shipped into distribution to retail facilities," according to the FDA. Handsome Brook Farms issued the voluntary ...
We are very excited to receive FDA clearance for the innovative SIMEOX 200 therapy for patients in the U.S.,” Kevin Smith, President and Chief Executive Officer, Inogen ...
The FDA has begun inspections of a company linked to a listeria outbreak, but has not released the name of the company. The Food and Drug Administration has also begun sample collection and ...
Almost exactly 10 years after the FDA’s initial FDA approval for Bristol Myers Squibb’s Opdivo as the first PD-1 inhibitor in the U.S., the agency has cleared an under-the-skin version of the ...
The Cabinet approved a special package for companies manufacturing DAP fertiliser. This initiative includes financial assistance in addition to the existing subsidies for DAP producers. “ ...
Subcutaneous nivolumab and hyaluronidase-nvhy is FDA-approved for adult solid tumors, offering a new administration route for PD-1 inhibitors. The phase 3 CheckMate-67T trial confirmed ...
The FDA approved several drugs in December for the treatment of diseases, including pancreatic adenocarcinoma, lung cancer, skin cancer and graft-versus-host disease. Throughout December, the Food and ...
The FDA’s Center for Drug Evaluation and Research (CDER) approved 50 new small molecules, biologics and oligonucleotide therapeutics last year. The class of 2024 was a little smaller than that ...
On December 25th Xinhua, the state-run news agency, reported that China had approved plans to build the world’s largest hydroelectric dam on the lower reaches of the Yarlung Tsangpo, which flows ...
The Food and Drug Administration (FDA) on Dec. 20 approved the obesity medication Zepbound (tirzepatide) as the first pharmaceutical treatment for moderate-to-severe obstructive sleep apnea (OSA) in ...